nivolumab,ipilimumab
bms
['nivolumab', 'ipilimumab', 'nivo', 'melanoma', 'thank you']
thank you, dr elizabeth buchbinder, of , for discussing the role of nivolumab maintenance in advanced melanoma following severe immune-related aes from nivolumab and ipilimumab. check back here to hear more from the experts: #asco23 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.